| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 鹭燕医药股份有限公司为福建省最大的医药流通企业，以药品、中药饮片、医疗器械和疫苗等分销及医药零售连锁为主营业务，并主要以对医药分销业务价值链中最重要终端——二级以上医院的纯销为最主要业务模式。公司经营的药品、中药饮片、医疗器械和疫苗等品种品规达38,693种，拥有上游供应商2,892家及下游客户10,481家。根据商务部全国医药批发企业百强排名，公司位次近3年持续提升，2013年位列第19位，已连续三年居福建省医药流通企业第一。同时，在2012年福建省八标采购中，公司中标品种委托配送总品规数排名全省第一。2014年8月，公司入选福建省2014年医疗机构药品集中采购之10家全省公立医疗机构基本药物配送企业，且得分排名第一。2014年12月公司子公司福建中宏成为福建省首家获得第三方药品物流资质的企业。公司在福建省医药零售领域亦处于领先地位。截至本招股说明书签署日，公司拥有直营零售药店128家，根据福建省药监局2013年6月底的药店明细数据统计，发行人下属门店家数在福建省零售连锁药店中位列第四，在厦门市零售连锁药店中位列第一。 | ||||||||||||||||||||||||
| Main Business | 药品、中药饮片、医疗器械等分销及医药零售连锁 | ||||||||||||||||||||||||
| Legal Representative | 吴金祥 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 叶泉青 | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 容诚会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0592-8129338 | ||||||||||||||||||||||||
| Fax No | 0592-8129310 | ||||||||||||||||||||||||
| Website | www.luyan.com.cn | ||||||||||||||||||||||||
| zqb@luyan.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 18/02/2016 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.940 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.300 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 7.583 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.358B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |